ALZAMEND NEURO, INC. Basic Shares Outstanding (Weighted Average)
ALZAMEND NEURO, INC. (ALZN) reported Basic Shares Outstanding (Weighted Average) of 4.48 million shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-10
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-07-31 was 4.48M shares, a 112.66% increase year-over-year.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-04-30 was 3.98M shares, a 457.27% increase year-over-year.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-01-31 was 3.80M shares, a 521.71% increase year-over-year.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-10-31 was 3.38M shares, a 761.59% increase year-over-year.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for fiscal 2026 was 3.34M shares, a 640.27% increase from fiscal 2025.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 450.80K shares, a 507.76% increase from fiscal 2024.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 74.17K shares, a 88.59% decline from fiscal 2023.
- ALZAMEND NEURO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 650.13K shares, a 99.27% decline from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 4.48M shares 10-Q · filed 2026-09-10 | 4.23M shares derived: average of 2 quarters · filed 2026-09-10 | 4.09M shares derived: average of 3 quarters · filed 2026-09-10 | 3.91M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2026-04-30 | 3.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-22 | 3.89M shares derived: average of 2 quarters · filed 2026-07-22 | 3.72M shares derived: average of 3 quarters · filed 2026-07-22 | 3.34M shares 10-K · filed 2026-07-22 | ||||
| 2026-01-31 | 3.80M shares 10-Q · filed 2026-03-11 | 3.59M shares derived: average of 2 quarters · filed 2026-03-11 | 3.12M shares 10-Q · filed 2026-03-11 | 2.50M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-10-31 | 3.38M shares 10-Q · filed 2025-12-09 | 2.78M shares 10-Q · filed 2025-12-09 | 2.07M shares derived: average of 3 quarters · filed 2026-09-10 | 1.70M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-07-31 | 2.11M shares 10-Q · filed 2026-09-10 | 1.41M shares derived: average of 2 quarters · filed 2026-09-10 | 1.14M shares derived: average of 3 quarters · filed 2026-09-10 | 956.26K shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-04-30 | 714.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-22 | 663.29K shares derived: average of 2 quarters · filed 2026-07-22 | 573.00K shares derived: average of 3 quarters · filed 2026-07-22 | 450.80K shares 10-K · filed 2026-07-22 | ||||
| 2025-01-31 | 611.98K shares 10-Q · filed 2026-03-11 | 5.52M shares 10-Q · filed 2025-03-10 | 502.19K shares derived: average of 2 quarters · filed 2026-03-11 | 362.86K shares 10-Q · filed 2026-03-11 | 3.28M shares 10-Q · filed 2025-03-10 | -157.92K shares derived: average of 4 quarters · filed 2026-03-11 | ||
| 2024-10-31 | 392.41K shares 10-Q · filed 2025-12-09 | 3.53M shares 10-Q · filed 2024-12-11 | 239.42K shares 10-Q · filed 2025-12-09 | 2.15M shares 10-Q · filed 2024-12-11 | -414.55K shares derived: average of 3 quarters · filed 2025-12-09 | -134.56K shares derived: average of 4 quarters · filed 2025-12-09 | ||
| 2024-07-31 | 85.31K shares 10-Q · filed 2025-09-10 | 777.82K shares 10-Q · filed 2024-09-11 | -818.03K shares derived: average of 2 quarters · filed 2025-09-10 | -310.21K shares derived: average of 3 quarters · filed 2025-09-10 | -68.56K shares derived: average of 4 quarters · filed 2025-09-10 | |||
| 2024-04-30 | -1.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-22 | -507.98K shares derived: average of 2 quarters · filed 2025-07-22 | -119.86K shares derived: average of 3 quarters · filed 2025-07-22 | 74.17K shares 10-K · filed 2025-07-22 | 676.57K shares 10-K · filed 2024-07-30 | |||
| 2024-01-31 | 705.43K shares 10-Q · filed 2025-03-10 | 7.05M shares 10-Q · filed 2024-03-25 | 680.90K shares derived: average of 2 quarters · filed 2025-03-10 | 672.69K shares 10-Q · filed 2025-03-10 | 6.73M shares 10-Q · filed 2024-03-25 | -3.73M shares derived: average of 4 quarters · filed 2025-03-10 | ||
| 2023-10-31 | 656.38K shares 10-Q · filed 2024-12-11 | 6.56M shares 10-Q · filed 2023-12-15 | 656.32K shares 10-Q · filed 2024-12-11 | 6.56M shares 10-Q · filed 2023-12-15 | -5.21M shares derived: average of 3 quarters · filed 2024-12-11 | -2.27M shares derived: average of 4 quarters · filed 2024-12-11 | ||
| 2023-07-31 | 656.27K shares 10-Q · filed 2024-09-11 | 98.44M shares 10-Q · filed 2023-09-13 | -8.15M shares derived: average of 2 quarters · filed 2024-09-11 | -3.25M shares derived: average of 3 quarters · filed 2024-09-11 | -810.50K shares derived: average of 4 quarters · filed 2024-09-11 | |||
| 2023-04-30 | -16.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -5.20M shares derived: average of 2 quarters · filed 2024-07-30 | -1.30M shares derived: average of 3 quarters · filed 2024-07-30 | 650.13K shares 10-K · filed 2024-07-30 | 97.52M shares 10-K · filed 2023-07-27 | |||
| 2023-01-31 | 6.56M shares 10-Q · filed 2024-03-25 | 6.53M shares derived: average of 2 quarters · filed 2024-03-25 | 6.52M shares 10-Q · filed 2024-03-25 | |||||
| 2022-10-31 | 6.50M shares 10-Q · filed 2023-12-15 | 6.50M shares 10-Q · filed 2023-12-15 | ||||||
| 2022-07-31 | 97.48M shares 10-Q · filed 2023-09-13 | |||||||
| 2022-04-30 | 89.10M shares 10-K · filed 2023-07-27 | |||||||
| 2021-04-30 | 72.65M shares 10-K · filed 2022-07-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |